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In trials of physical and talking therapies or group admi-
nistered treatments, clustering of patients within care-
provider or treatment group has implications for sample
size and statistical analysis analogous to those found in
cluster randomised trials [1]. Between-cluster variation
reduces precision and power when estimating treatment
effects. Statistical analyses that fail to take account of
this form clustering rest on the assumption of no clus-
tering effect and may therefore lack conclusion validity.
In trials with treatment related clustering, the cluster
size may differ systematically between treatment arms,
due to differing number of therapists in each arm or dif-
ferences in the size of therapy groups between arms. The
intra-cluster correlation due to therapist or therapy
group may also differ between treatment arms. An
extreme case of such heterogeneity is the partially nested
design in which the clustering effect is absent in one
treatment arm. Where both cluster size and the underly-
ing variance components differ between treatments, fail-
ure to correctly model heterogeneity can bias estimates
of the intra-cluster correlation coefficient and test size
[1]. This contrasts with cluster-randomised trials where
the distribution of cluster sizes in each treatment arm
will be similar due to randomisation making cluster ran-
domised trials robust to heteroscedasticity.
In a cluster randomised trial, it is generally assumed
that each subject belongs to just a single unit of rando-
misation so that the design is hierarchical. In non-phar-
macological therapy trials patients may receive
treatment from more than one therapist or in more
than one therapy group so the multilevel model is no
longer strictly hierarchical. Statistical analysis will
therefore require simplifying assumptions regarding the
pattern of clustering such as use of a primary therapist
or primary group for each patient or the application of
a multiple membership model [2].
In conclusion, analysis of trials with treatment related
clustering may therefore require more complex methods
of analysis than cluster randomised trials.
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